Concepedia

Daniel B. Kennedy

DB

Statistics

Publications

10

Citations

564

H-Index

10

Active since

1975

Affiliations

Leicester Royal Infirmary(Current)

Royal Liverpool University Hospital

University of Liverpool

Royal Marsden Hospital

Heartlands Hospital

Daniel B. Kennedy is an author at Leicester Royal Infirmary specializing in medicine, rituximab-based therapy, and pharmacotherapy.

Publications per year

1975–2014

10

Publications

10

Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1

Marion MacFarlane, Satoshi Inoue, Susan Kohlhaas et al. · Cell Death and Differentiation · 2005 · 150 citations

Life Sciences, Cell Biology, Oncology +12

Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study

Peter Hillmen, John G. Gribben, George Follows et al. · Journal of Clinical Oncology · 2014 · 121 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Police Background Characteristics and Performance.

Daniel B. Kennedy, Bernard L. Cohen, Jan M. Chaiken · Contemporary Sociology A Journal of Reviews · 1975 · 108 citations

Social Sciences, Criminology, Public Administration +10

BCL2 expression in chronic lymphocytic leukemia: lack of association with the BCL2 −938A>C promoter single nucleotide polymorphism

Aneela Majid, Olga Tsoulakis, Renata Walewska et al. · Blood · 2007 · 48 citations

Life Sciences, Genetics, Molecular Biology +8

A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia

Peter Hillmen, D. Cohen, Kim Cocks et al. · British Journal of Haematology · 2011 · 41 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

1–5 of 10